HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Goetghebeur, D. Articles by Bellet, M. Search for Related Content PubMed PubMed Citation Articles by Goetghebeur, D. Articles by Bellet, M.

Tidal expiratory flow limitation and chronic dyspnoea in patients with cystic fibrosis

¹ Unité d'Explorations Fonctionelles Respiratoires, Service de Pneumologie, Université de Bretagne Occidentale, Centre Hospitalier Universitaire, Brest, France. ² Meakins-Christie Laboratories, McGill University, Montreal, Canada

CORRESPONDENCE: M. Bellet, Unité d'Explorations Fonctionelles Respiratoires, Hôpital Morvan, 29609, Brest, France. Fax: 33 298223959. E-mail: mireille.bellet@univ-brest.fr

Keywords: Body plethysmography, bronchodilator, cystic fibrosis, dynamic hyperinflation, lung function

Received: March 2, 2001
Accepted November 24, 2001

Cystic fibrosis (CF) eventually leads to hyperinflation linked to tidal expiratory flow limitation (FL) and ventilatory failure.

Presence of FL was assessed at rest in 22 seated children and adults with CF (forced expiratory volume in one second (FEV₁) range: 16–92% predicted), using both the negative expiratory pressure (NEP) technique and the "conventional" method based on comparison of tidal and maximal expiratory flow/volume curves. In addition, chronic dyspnoea was scored with the modified Medical Research Council (MRC) scale. Measurements were made before and 15 min after inhalation of salbutamol.

With NEP, FL was present in only three malnourished patients, who had the lowest FEV₁ values (16–27% pred) and claimed very severe dyspnoea (MRC score 5). By contrast, an additional seven patients were classified as FL with the conventional method. Six of these patients had little or no dyspnoea (MRC scores 0–1). Salbutamol administration had no effect on the extent of FL, and the concomitant decrease in functional residual capacity (FRC) was too small to play any clinically significant role.

This study concluded that in seated patients with cystic fibrosis, expiratory flow limitation is absent at rest, unless the forced expiratory volume in one second is <30% predicted. If present, expiratory flow limitation is associated with severe chronic dyspnoea. The conventional method for assessing expiratory flow limitation is not reliable and bronchodilator administration has little effect on expiratory flow limitation.

This article has been cited by other articles:

				A. E. Holland, L. Denehy, and J. W. Wilson Does expiratory flow limitation predict chronic dyspnoea in adults with cystic fibrosis? Eur. Respir. J., July 1, 2006; 28(1): 96 - 101. [Abstract] [Full Text] [PDF]

				P. M. A. Calverley and N. G. Koulouris Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology Eur. Respir. J., January 1, 2005; 25(1): 186 - 199. [Abstract] [Full Text] [PDF]

				R. L. Colasanti, M. J. Morris, R. G. Madgwick, L. Sutton, and E. M. Williams Analysis of Tidal Breathing Profiles in Cystic Fibrosis and COPD Chest, March 1, 2004; 125(3): 901 - 908. [Abstract] [Full Text] [PDF]

				N.G. Koulouris, S. Retsou, E. Kosmas, K. Dimakou, K. Malagari, G. Mantzikopoulos, A. Koutsoukou, J. Milic-Emili, and J. Jordanoglou Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis Eur. Respir. J., May 1, 2003; 21(5): 743 - 748. [Abstract] [Full Text] [PDF]